Efficacy of Bydureon in Adults with Type 2 Diabetes

Efficacy of Bydureon in Adults with Type 2 Diabetes

Type 2 diabetes is still rapidly on the rise today, affecting 10.5% of individuals in the United States between the ages 45 to 64 and 18.4% of those between the ages of 65 to 74. In the past two decades, type 2 diabetes has doubled in all age groups. Many adults with type 2 diabetes experience diffi...

Full description

Bibliographic Details
Main Author: Fetter, Katie L.
Format: Others
Published: UNF Digital Commons 2014
Subjects:
Thesis
University of North Florida
UNF
Dissertations
Academic > UNF > Master of Science in Nursing
Academic > UNF > Nursing
Bydureon
Type 2 Diabetes
GLP 1 receptor agonist
Glucagon-like peptide 1 > Effectiveness > Testing
Non-insulin-dependent diabetes > Treatment > Testing
Family Practice Nursing
Medicine and Health Sciences
Nursing
Online Access:http://digitalcommons.unf.edu/etd/490
http://digitalcommons.unf.edu/cgi/viewcontent.cgi?article=1525&context=etd

Internet

http://digitalcommons.unf.edu/etd/490
http://digitalcommons.unf.edu/cgi/viewcontent.cgi?article=1525&context=etd

Similar Items